Provided herein are methods for the treatment of anemia, wherein the methods comprise administration of antagonists of Growth differentiation factor 11 (GDF-11; also known as bone morphogenetic protein 11 (BMP11)) to a subject in need of the treatment. The GDF11 antagonists include ActRIIA polypeptides, ActRIIB polypeptides and anti-GDF-11 antibodies.